MWAIOTCFinance ServicesFiscal year ends June 30

MedWellAI, Inc.

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Oct 13, 2026

$0.20−0.12 (-37.50%)

Close on Oct 19, 2026

Market cap: –
P/E (TTM): –
Dividend yield: –

MedWellAI, Inc. income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2026 2026-06-30	FY 2025 2025-06-30	FY 2024 2024-06-30	FY 2023 2023-06-30	FY 2022 2022-06-30	FY 2021 2021-06-30	FY 2020 2020-06-30	FY 2019 2019-06-30	FY 2018 2018-06-30	FY 2017 2017-06-30	FY 2016 2016-06-30	FY 2015 2015-06-30	FY 2013 2013-03-31	FY 2012 2012-03-31
Revenue	0.53	0.59	0	3.86	6.55	1.85	0.45	0.28	0.31	–	–	–	–	–
Cost of Revenue	–	–	3.93	2.70	3.87	0.92	1.00	1.01	0.24	–	–	–	–	–
Gross Profit	–	–	-3.93	-2.43	2.68	0.93	-0.54	-0.73	0.07	–	–	–	–	–
Research & Development	–	–	–	–	–	–	–	–	–	0.02	0.12	–	–	–
Selling, General & Admin	–	2.68	9.28	–	–	–	–	–	–	–	–	–	0.00	0.00
Selling & Marketing	–	0.07	0	–	–	–	–	–	–	–	–	–	–	–
General & Administrative	1.66	2.62	9.28	16	3.22	23	0.35	1.82	1.30	0.99	3.35	0.02	–	–
Operating Expenses	–	–	–	23	3.37	23	0.47	3.92	6.20	1.01	3.47	0.26	0.00	0.05
Operating Income	-1.24	-2.84	-9.07	-25	-0.69	-22	-1.01	-4.65	-6.14	-1.01	-3.47	-0.26	–	–
Interest Expense	0.05	0.05	0.08	0.28	0.02	0.44	0.66	0.21	-0.15	–	–	–	0.00	0.00
Other Non-Operating Income	-0.28	-0.11	-0.08	-0.29	0.12	-0.76	-0.07	-4.87	0.56	–	–	–	–	–
Asset Impairment Charges	0.04	0.75	0	5.57	–	–	0	2.10	4.91	–	–	–	–	–
Gain (Loss) on Investments	–	–	–	–	–	–	-0.01	0	0.24	0.03	–	–	–	–
Gain (Loss) on Sale of Assets	–	0	-0.37	-1.20	-0.05	0	-0.16	0	0.05	0.00	-0.02	0.01	–	–
Legal Settlements	–	–	–	–	–	–	–	-0.50	-0.03	–	–	–	–	–
Pretax Income	-1.52	-2.95	-9.15	-25	-0.57	-22	-1.08	-9.51	-5.58	-1.76	-5.03	–	–	–
Income Tax Expense	0	0	0	0	0	0	0	0	–	–	–	–	–	–
Income from Continuing Operations	-1.52	-2.95	-9.15	–	–	–	–	–	–	–	–	–	–	-0.05
Income from Discontinued Operations	-0.07	-0.83	-2.37	–	–	–	–	–	–	–	–	–	–	–
Net Income incl. Noncontrolling Interests	-1.59	-3.78	-12	25	0.57	0.00	–	–	–	–	–	–	–	–
Minority Interest in Earnings	0.00	-0.17	0	–	–	–	–	–	–	–	–	–	–	–
Net Income	-1.59	-3.61	-12	-25	-0.57	-22	-1.08	-9.51	-5.58	-1.76	-5.03	-0.34	-0.03	-0.05
Preferred Dividends	–	–	–	–	–	0.19	0	–	–	–	–	–	–	–
Net Income to Common	–	-3.61	-12	-27	-1.12	-23	-1.08	–	–	–	–	–	-0.03	-0.05
EPS (Basic)(per share)	–	–	-2.72	-11.98	-1.25	-20.00	-2.50	-87.50	-83.75	–	–	–	–	-25.00
EPS (Diluted)(per share)	–	–	-2.72	-11.98	–	-20.00	-2.50	-87.50	-83.75	–	–	–	–	-25.00
Shares Outstanding (Basic, Weighted)(shares)	–	–	4.41	2.25	1.64	1.17	0.52	0.11	0.07	0.01	0.00	0.00	0.00	0.00
Shares Outstanding (Diluted, Weighted)(shares)	–	–	4.41	2.25	1.64	1.17	0.52	0.11	0.07	0.01	0.00	0.00	0.00	0.00
EBITDA	-1.20	-2.81	-9.07	-22	0.93	-21	-0.44	-4.09	-6.08	–	-3.47	-0.26	–	–
Net Interest Income	–	–	–	–	–	–	–	–	-0.15	-0.68	-0.48	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2026

Gross margin: –
Operating margin: -234.2%
Net margin: -301.1%
Return on equity, FY2026: 21.8%

Financial strength

Current ratio: 0.01
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 1.1%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –